Agilent Technologies (A) Stock: Buy, Sell, or Hold?
$173.01
-3.94 (-2.23%)
âŧ
5d:
+0.72%
30d:
-0.57%
90d:
+16.48%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 23, 2026
9d
Protect A Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (44%)
Quality Score
35/100
Position
FAIR
30-Day Fair Range
$170.69 â $177.70
Position: FAIR
Forward P/E & Valuation
25.8x
STRETCHED
vs 21.1x historical avg
Wall Street Target
$182.05
+5.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$171.07 / $181.27
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: A is fairly priced but lacks strong directional signals. At 6.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Get Alerted When A Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$191.43
Based on 6.2% avg growth
INTRINSIC VALUE TODAY
$118.86
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: A is currently trading at $173.01, which is considered fair relative to its 30-day fair value range of $170.69 to $177.70. From a valuation perspective, the stock is trading at a premium (Forward PE: 25.8) compared to its historical average (21.1). At these levels, the market is pricing in 6.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, A is in a strong uptrend. The price is currently testing key support at $171.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: A scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, A is in a strong uptrend. The price is currently testing key support at $171.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: A scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$170.69 -
$177.70
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
44.3%
Trading Range & Key Levels
30-Day Trading Range
$170.69 -
$177.70
Current vs Trading Range
FAIR
Support Level
$171.07
Resistance Level
$181.27
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding A? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($182.05)
- NEUTRAL: Trading at premium valuation - market expects 6.9% growth which is achievable
- WARNING: Composite score 35/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
25.75
Wall Street Target
$182.05
(+5.2%)
Revenue Growth (YoY)
8.1%
Earnings Growth (YoY)
8.5%
Profit Margin
19.5%
Valuation Premium vs History
+6.9% premium
PE vs Historical
25.8 vs 21.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.9%
(market-implied from PE analysis)
1-Year Target
$184.95
(+7%)
2-Year Target
$197.71
(+14%)
3-Year Target
$211.35
(+22%)
3-Yr Target (if PE normalizes)
(PE: 26â21)
PE COMPRESSION
$173.20
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.7, Growth: 8.4%)
$220.09
(+27%)
Base:
(SPY PE: 19.9, Growth: 8.4%)
$169.76
(-2%)
Bear:
(PE: 16.9, Growth: 8.4%)
$144.30
(-17%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (26x PE) as earnings recover.
Trailing PE: 35.11 | Current EPS (TTM): $5.04
Bull Case
$259.51
(+50%)
Analyst growth 33.3%, PE expands to 38.6
Base Case
$235.92
(+36%)
Market implied 33.3%, PE stable at 35.1
Bear Case
$120.33
(-31%)
Severe decline -20.0%, PE contracts to 29.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share A Analysis
Share this live A analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (A)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
The global capillary electrophoresis market is projected to reach US$1.1 billion by 2032, driven by increasing demand for high-resolution analytical technologies, expanding pharmaceutical and biotechnology research, and continued innovation in capillary electrophoresis-mass spectrometry (CE-MS), automated platforms, and microchip-based systems.
Key Retail Themes:
Capillary Electrophoresis market growth
Innovation in CE-MS, automated platforms, and microchip-based systems
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 6:58 PM ET
Data refreshes hourly during market hours. Next update: 7:58 PM
Data refreshes hourly during market hours. Next update: 7:58 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is A showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 67 BUY |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
27 analysts |
$752 | 48 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 50 HOLD |
Advanced A Option Strategies
Professional options setups generated by AI based on today's A price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive A Research Pages
